Spontaneous activation of serum C1 in vitro. Role of C1 inhibitor
- PMID: 1890306
Spontaneous activation of serum C1 in vitro. Role of C1 inhibitor
Abstract
The temperature and ionic strength dependence of the spontaneous activation of C1 were determined for normal human serum, and the free energy, enthalpy, and entropy of spontaneous activation were calculated. The half-life of C1 in human serum was approximately 15 h at 37 degrees C. This half-life was markedly extended by dilution with C1-depleted serum, and an extrapolated upper limit of 40 to 50 h was reached at infinite dilution. Thus, the spontaneous activation of C1 in serum appeared to involve a dilution-sensitive reaction as well as a dilution-insensitive, first order reaction. A reaction mechanism was developed combining: 1) first order spontaneous activation of C1; 2) second order, C1-catalyzed activation of C1; and 3) second order inactivation of C1 by C1-inhibitor. A steady state equation was derived from this reaction mechanism, which provided a reasonable fit to the experimental data. The equation predicts that when the C1-inhibitor concentration decreases so that the steady state condition is lost, the concentration of C1 builds up quickly, and activation of most of the C1 occurs rapidly.
Similar articles
-
A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.J Immunol. 1988 Dec 1;141(11):3930-6. J Immunol. 1988. PMID: 3183385
-
Spontaneous activation of reconstituted and serum C1 and the role of C1-inhibitor.Behring Inst Mitt. 1989 Jul;(84):102-10. Behring Inst Mitt. 1989. PMID: 2803179
-
Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.J Immunol. 1982 Jun;128(6):2500-4. J Immunol. 1982. PMID: 6281332
-
C1 subcomponent complexes: basic and clinical aspects.Behring Inst Mitt. 1993 Dec;(93):292-8. Behring Inst Mitt. 1993. PMID: 8172579 Review.
-
Structure and function of C1 inhibitor.Behring Inst Mitt. 1989 Jul;(84):142-50. Behring Inst Mitt. 1989. PMID: 2679529 Review.
Cited by
-
Systems Biology Modeling of the Complement System Under Immune Susceptible Pathogens.Front Phys. 2021 Apr 29;9:603704. doi: 10.3389/fphy.2021.603704. Front Phys. 2021. PMID: 35145963 Free PMC article.
-
C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities.Immunology. 1998 Dec;95(4):648-54. doi: 10.1046/j.1365-2567.1998.00635.x. Immunology. 1998. PMID: 9893058 Free PMC article.
-
Production of multidomain complement glycoproteins in insect cells.Cytotechnology. 1996 Jan;20(1-3):279-88. doi: 10.1007/BF00350407. Cytotechnology. 1996. PMID: 22358491 No abstract available.
-
Eosinophil granule cationic proteins regulate the classical pathway of complement.Immunology. 1995 Feb;84(2):213-9. Immunology. 1995. PMID: 7750997 Free PMC article.
-
Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):986-991. doi: 10.1073/pnas.1616998114. Epub 2017 Jan 19. Proc Natl Acad Sci U S A. 2017. PMID: 28104818 Free PMC article.